Reports for FRESENIUS KABI CANADA LTD

Company Name

FRESENIUS KABI CANADA LTD

Totals

Shortage reports

307

Actual shortage: 12 (4%)
Anticipated shortage: 1 (0%)
Avoided shortage: 5 (2%)
Resolved: 289 (94%)

Discontinuation Reports

0

To be discontinued: 0
Discontinued: 0
Reversed: 0

Late reports

48 (16%)

Overdue reports

5 (38%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
DIPYRIDAMOLE INJECTION, USP 5MG LIQUID Resolved 2022-10-03 2023-04-03 170977
DIPYRIDAMOLE INJECTION, USP 5MG LIQUID Actual shortage 2023-06-02 2024-03-28 193649
KETOROLAC TROMETHAMINE INJECTION, USP 30MG LIQUID Resolved 2019-01-08 2019-01-19 71575
KETOROLAC TROMETHAMINE INJECTION, USP 30MG LIQUID Resolved 2019-01-22 2019-04-06 73209
KETOROLAC TROMETHAMINE INJECTION, USP 30MG LIQUID Resolved 2023-06-14 2023-08-01 194929
KETOROLAC TROMETHAMINE INJECTION, USP 30MG LIQUID Resolved 2024-01-31 2024-02-20 217938
INTRALIPID 20% 20% EMULSION Resolved 2021-09-10 2021-10-22 145481

Showing 301 to 307 of 307

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports

Showing 1 to 0 of 0